Neoplasms, Unknown Primary: all 107 studies
Page 2 of 2. Open to participants first (18), then studies with results posted, then the rest; newest registration first within each.
- Irinotecan in Treating Patients With Advanced Neuroendocrine TumorsCompletedNCT00004922Phase 2
- Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuCompletedNCT00004074Phase 1
- Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary OriginCompletedNCT00004005Phase 2
- Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer.CompletedNCT00003943Phase 2
- High-dose ICE With AmifostineCompletedNCT00003657Phase 2
- Chemotherapy in Treating Patients With Cancer of Unknown Primary OriginStatus unknownNCT00003558Phase 3
- Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck CancerCompletedNCT00002507Phase 3